l 
 l 
 l 
 l 
 l 
 l 
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Press Releases

12th December 2012
Enigma awarded Biomedical Catalyst grant to develop MDR TB assay
pdf



 

10 August 2011
Enigma Diagnostics and GSK announce Collaboration on Assay Development and Commercialization of Enigma’s ML Platform
pdf

18 July 2011
Successful completion of EU Framework 7 RANGER project
pdf



 

11 January 2011
Tecan and Enigma Diagnostics sign licence and collaboration agreement
pdf

18 October 2010
Enigma Diagnostics’ Patents Maintained by UK Intellectual Property Office
pdf

21 July 2010
Enigma Diagnostics to Feature the Enigma ML at the American Association for Clinical Chemistry Expo in Anaheim, California 25 to 29 July 2010
pdf

22 April 2010
Enigma Diagnostics Showcases the Enigma ML as a Service Provider at InnovHealth Summit 2010 in Abu Dhabi
pdf

19 April 2010
US Patent Covering Amplification Consumables Granted to Enigma Diagnostics Limited
pdf

4 March 2010
Enigma Diagnostics Announces New San Diego Office and Appointment of Joel Centeno, VP Regulatory & Quality
pdf

5 February 2010
Tecan and Enigma Diagnostics sign global manufacturing and supply agreement for point-of-care Molecular Diagnostics instruments
pdf

15 January 2010
Enigma ML System to Demonstrate Rapid Detection of Swine H1N1 Influenza at Arab Health 2010
pdf

25 November 2009
Enigma Diagnostics Expands its US and European Executive Management Teams
pdf

18 November 2009
Enigma Diagnostics Showcases its Unique Fully Automated rtPCR based ML (Mini Laboratory) Instrument for Point-of-Care Testing at Medica 2009 in Dusseldorf, Germany
pdf

21 July 2009
GSK and Enigma Diagnostics Announce Commercial Partnership to Develop Point-of-Care Influenza Diagnostics
pdf

16 July 2009
Enigma Diagnostics Announces Signing of Patent Licenses with Roche Molecular Systems, Inc.
pdf

30June 2009
Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK's Veterinary Laboratories Agency
pdf

16 June 2009
Enigma Diagnostics Announces Patent on Real -Time Monitoring of Amplification Reactions Upheld in Entirety following Opposition from BD at European Patent Office
pdf

27 February 2009
Enigma Diagnostics Finalist in 2009 International Healthcare Associated Infections Awards
pdf

16 December 2008
Enigma Diagnostics Announces A Signed Term Sheet For Patent Licenses with Roche Molecular Systems, Inc.
pdf

4 December 2008
Enigma Diagnostics Announces ISO 9001:2000 Certification
pdf

2 December 2008
Enigma Diagnostics Announces the Opening of a United States Office
pdf

18 November 2008
Enigma Diagnostics Launches Field Laboratory (FL) System
pdf

22 October 2008
Enigma Diagnostics Announces Patent Licence with Applied Biosystems
pdf

18 September 2008
Enigma Diagnostics Announces an Award of £1.8 million from UK Government
pdf

7 February 2008
Enigma signs real-time PCR licences with Applera
pdf

9 November 2007
Enigma Diagnostics to develop clinical diagnostics platform for UK National Chlamydia Screening Programme
pdf

3 October 2007
Enigma Diagnostics Announces A European Commission Award
pdf

22 August 2007
Enigma Diagnostics Signs New Exclusive Licence Agreement with the Defence Science and Technology Laboratory (Dstl)
pdf

28 March 2007
Enigma Diagnostics' Enigma FL System Rapidly Detects Infectious Organisms in Successful Field Trials
pdf

18 December 2006
Enigma Diagnostics Appoints Professor Christopher Lowe as Non-Executive Director
pdf

18 June 2006
Enigma Diagnostics Launches the First Molecular Diagnostics Product for Detection of Biological Threats in the Field
pdf